Study on chemical exposure and breast cancer
Part of Cancer, Skin clinical trials.
This study looks at whether everyday chemicals called endocrine disruptors are linked to breast cancer. It will test tissue samples from women having breast surgery to find markers in the body that might show this link.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are female
- You have a scheduled surgery to remove a breast lesion
- You have signed a consent form after learning about the study
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how chemicals in the environment (called endocrine disruptors) might affect the natural bacteria in your gut and whether that could play a role in colorectal cancer. If you are having a colonoscopy (endoscopy), you may be able to participate.
This study looks at breast cancer samples taken by biopsy to see how tissue “molecular markers” relate to how you respond to therapy and how the cancer behaves. It may help researchers better match future treatments to the biology of your tumor.
This study looks at substances in your blood (metabolites) to see if they are linked to breast cancer risk, how well treatment works, and long-term outcomes. It has three groups: women without breast cancer, newly diagnosed patients getting standard therapy, and those who have finished treatment.
This study looks at tiny particles released by cells (called extracellular vesicles) in people with breast cancer. It may help researchers better understand breast cancer and how it behaves, which could improve future testing or treatments.
This study looks at how bacteria in your gut might relate to breast cancer. By comparing tissue samples from your tumor and nearby healthy tissue, researchers hope to find new ways to understand or treat breast cancer.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.